Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1.

von Moore, J P, Cao, Y, Ho, D D, Koup, R A
Veröffentlicht 1994

Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus t...

von Connor, R I, Paxton, W A, Sheridan, K E, Koup, R A
Veröffentlicht 1996

Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules.

von Gauduin, M C, Allaway, G P, Maddon, P J, Barbas, C F, Burton, D R, Koup, R A
Veröffentlicht 1996

Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.

von Koup, R A, Sullivan, J L, Levine, P H, Brewster, F, Mahr, A, Mazzara, G, McKenzie, S, Panicali, D
Veröffentlicht 1989

Expansion of activated human naïve T-cells precedes effector function

von BRENCHLEY, J M, DOUEK, D C, AMBROZAK, D R, CHATTERJI, M, BETTS, M R, DAVIS, L S, KOUP, R A
Veröffentlicht 2002

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

von Koup, R A, Safrit, J T, Cao, Y, Andrews, C A, McLeod, G, Borkowsky, W, Farthing, C, Ho, D D
Veröffentlicht 1994

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans.

von Cheeseman, S H, Hattox, S E, McLaughlin, M M, Koup, R A, Andrews, C, Bova, C A, Pav, J W, Roy, T, Sullivan, J L, Keirns, J J
Veröffentlicht 1993

Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans

von Ledgerwood, J. E., Hu, Z., Gordon, I. J., Yamshchikov, G., Enama, M. E., Plummer, S., Bailer, R., Pearce, M. B., Tumpey, T. M., Koup, R. A., Mascola, J. R., Nabel, G. J., Graham, B. S.
Veröffentlicht 2012

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults

von Ledgerwood, J E, Coates, E E, Yamshchikov, G, Saunders, J G, Holman, L, Enama, M E, DeZure, A, Lynch, R M, Gordon, I, Plummer, S, Hendel, C S, Pegu, A, Conan-Cibotti, M, Sitar, S, Bailer, R T, Narpala, S, McDermott, A, Louder, M, O'Dell, S, Mohan, S, Pandey, J P, Schwartz, R M, Hu, Z, Koup, R A, Capparelli, E, Mascola, J R, Graham, B S
Veröffentlicht in Clin Exp Immunol (2015)

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

von Bar, K.J., Sneller, M.C., Harrison, L.J., Justement, J.S., Overton, E.T., Petrone, M.E., Salantes, D.B., Seamon, C.A., Scheinfeld, B., Kwan, R.W., Learn, G.H., Proschan, M.A., Kreider, E.F., Blazkova, J., Bardsley, M., Refsland, E.W., Messer, M., Clarridge, K.E., Tustin, N.B., Madden, P.J., Oden, K.S., O’Dell, S.J., Jarocki, B., Shiakolas, A.R., Tressler, R.L., Doria-Rose, N.A., Bailer, R.T., Ledgerwood, J.E., Capparelli, E.V., Lynch, R.M., Graham, B.S., Moir, S., Koup, R.A., Mascola, J.R., Hoxie, J.A., Fauci, A.S., Tebas, P., Chun, T.-W.
Veröffentlicht in N Engl J Med (2016)

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

von Ewer, K., Rampling, T., Venkatraman, N., Bowyer, G., Wright, D., Lambe, T., Imoukhuede, E.B., Payne, R., Fehling, S.K., Strecker, T., Biedenkopf, N., Krähling, V., Tully, C.M., Edwards, N.J., Bentley, E.M., Samuel, D., Labbé, G., Jin, J., Gibani, M., Minhinnick, A., Wilkie, M., Poulton, I., Lella, N., Roberts, R., Hartnell, F., Bliss, C., Sierra-Davidson, K., Powlson, J., Berrie, E., Tedder, R., Roman, F., De Ryck, I., Nicosia, A., Sullivan, N.J., Stanley, D.A., Mbaya, O.T., Ledgerwood, J.E., Schwartz, R.M., Siani, L., Colloca, S., Folgori, A., Di Marco, S., Cortese, R., Wright, E., Becker, S., Graham, B.S., Koup, R.A., Levine, M.M., Volkmann, A., Chaplin, P., Pollard, A.J., Draper, S.J., Ballou, W.R., Lawrie, A., Gilbert, S.C., Hill, A.V.S.
Veröffentlicht in N Engl J Med (2015)